Edgewise Therapeutics's total assets for Q2 2025 were $613.33M, an increase of 34.98% from the previous quarter. EWTX total liabilities were $24.26M for the fiscal quarter, a -1.66% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.